01.10.2010 | Original report | Ausgabe 3/2010

Very low rates of neutropenic complications and chemotherapy dose modifications in early breast cancer patients receiving adjuvant FEC-100 or TAC and an individualised G-CSF and anti-infective support: results of a retrospective chart review
- Zeitschrift:
- memo - Magazine of European Medical Oncology > Ausgabe 3/2010